bioRxivMicrobiology
A pseudovirus-based method to dynamically mimic SARS-CoV-2-associated cell-to-cell fusion and transmission
Abstract
SARS-CoV-2 has caused the global tremendous loss and continues to evolve to generate variants. Entry of SARS-CoV-2 into the host cells is primarily mediated by Spike (S), which binds to the host receptor hACE2 and initiates virus-cell membrane fusion. Cell fusion contributes to viral entry, cell-to-cell transmission and tissue damage in COVID-19 patients. Many reporter assays have been developed to study S-mediated cell fusion by equally coculturing S-expressing cells and hACE2-positive cells. However, these strategies cannot fully simulate cell-to-cell fusion and transmission of SARS-CoV-2 infection, in which virions from a single target cell transmit to the neighbor cells and induce syncytia formation. Here, we design a pseudovirus-based method to dynamically mimic cell-to-cell fusion and transmission of SARS-CoV-2. We coculture a small number of pseudovirus-producing 293FT cells and a large number of hACE2-expressing 293T cells, and demonstrate that a single cell producing S-pseudotyped virions can induce significant syncytia of hACE2-positive cells. This pseudovirus-based method is a powerful tool to screen and estimate potential inhibitors of S-driven syncytia. Moreover, this strategy can also be utilized to explore fusogenic ability of SARS-CoV-2 variants. Together, the pseudovirus-based method we report here will be beneficial to drug screening and scientific research against SARS-CoV-2 or future emerging coronavirus.
- organism: human
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation
B. F. Hörnich, A. K. Grosskopf, … A. S. Hahn·Journal of VirologyPeer-reviewed·Apr 12, 2021
- In silico, in vitro and in cellulo models for monitoring SARS-CoV-2 spike/human ACE2 complex, viral entry and cell fusion
D. Lapaillerie, C. Chariler, … V. Parissi·bioRxiv·Feb 3, 2021
- Expression and fusogenic activity of SARS CoV-2 Spike protein displayed in the HSV-1 Virion.
P. J. Desai·bioRxiv·Nov 28, 2023
- SARS-CoV-2 Spreads through Cell-to-Cell Transmission
C. Zeng, J. P. Evans, … S.-L. Liu·bioRxiv·Jun 1, 2021
- Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
S. A. Theuerkauf, A. Michels, … C. J. Buchholz·bioRxiv·Oct 15, 2020
- Curcumin and turmeric extract inhibit SARS-CoV-2 pseudovirus cell entry and Spike mediated cell fusion
E. P. P. Septisetyani, D. Lestari, … K. Eriani·bioRxiv·Sep 28, 2023